Mesothelioma Medical Treatment
Options
The
primary treatment options for malignant mesothelioma are surgery, radiation therapy and chemotherapy.
Mesothelioma
Surgery
Before any surgery
is considered for the treatment of malignant mesothelioma, the patient's
overall health is carefully evaluated. Tests are performed to make sure
the patient has no metastatic disease (cancer spread to distant sites)
and to evaluate the patient's pulmonary (lung) and cardiac (heart) function.
Pulmonary function is often compromised in patients with pleural mesothelioma
for several reasons. The pleural effusion (fluid collection) and the tumor
mass caused by mesothelioma can compress the lung. Also, the patient's
exposure to asbestos may have decreased lung function, which also decreases
with age. In addition, some patients have a history of smoking cigarettes,
which further decreases lung function.Surgery
for malignant mesothelioma may be aimed at cure (aggressive surgery) or
relief of symptoms (palliative procedures).
Aggressive
surgery - Extrapleural pneumonectomy involves removal of the
pleura, the lung, the diaphragm and the pericardium. The intent of this
very aggressive, complicated surgery is to remove as much of the tumor
as possible. Not all centers will perform this procedure because of its
complexity and because it carries a high risk of postoperative mortality
(death within 30 days after surgery). Extrapleural pneumonectomy is typically
performed only in younger patients in good overall health with stage I
disease. Patients are evaluated carefully to determine their ability to
tolerate the surgery. Palliative procedures - When malignant mesothelioma
is advanced, palliative procedures may be performed to relieve and/or
control symptoms such as breathlessness and pain, which are caused by
effusion (fluid collection) or by the tumor compressing the lung or other
organs. These procedures do not aim to cure the disease.
- Thoracentesis may be used to treat effusion in pleural mesothelioma. A needle is
inserted into the chest to drain the fluid, relieving breathlessness
and pain. Talc may be introduced into the pleura to prevent recurrence
of the effusion. Similar procedures are used to treat ascites (fluid
collection) in peritoneal mesothelioma.
- Pleurectomy
/ decortication is the surgical removal of the pleura. This
procedure may be performed to reduce pain caused by the tumor mass
or to prevent the recurrence of pleural effusion. For peritoneal mesothelioma,
surgery is generally aimed at relieving symptoms, such as recurrent
ascites or bowel obstruction.
As with pleural mesothelioma, complete surgical removal of the entire
tumor is unlikely.
Mesothelioma - Radiation
Therapy
Because
of the location of malignant mesothelioma, it is extremely difficult to
deliver high enough doses of radiation to kill the tumor without damaging
the surrounding organs. Lower doses of radiation may result in some reduction
in the disease, but it is unclear whether this reduction actually results
in longer survival than does no treatment.
Using
radiation therapy after surgery has not been shown to improve survival.
However, because surgery is very unlikely to remove the entire tumor,
radiation is commonly administered after surgery in the hopes of killing
remaining tumor cells. In addition, radiation therapy can be used to relieve
symptoms of mesothelioma, including pain and shortness of breath.
Mesothelioma - Chemotherapy
Chemotherapy - the
use of medications to treat cancer - has had disappointing results in
the treatment of malignant mesothelioma. Some chemotherapy drugs have
a partial effect in some patients. Combination chemotherapy (using more
than one drug at the same time) may be given in an attempt to improve
response. Some combinations have shown some promise, and some new medications
are being tried. Like radiation
therapy, chemotherapy may be administered after surgery in an attempt
to kill cancer cells that could not be removed during the procedure. Mesothelioma
- Treatment By Stage Pleural
mesothelioma can be treated according to stage; there are no standard
treatment options by stage for peritoneal mesothelioma. Stage I (localized)
mesothelioma - If a patient wants aggressive treatment and
is deemed fit to undergo surgery, some centers may perform an extrapleural
pneumonectomy. Another surgical option is pleurectomy/decortication,
which is sometimes performed to alleviate some of the symptoms of mesothelioma.
Both of these procedures may be followed by radiation therapy or chemotherapy.
Alternatively, radiation therapy may be used alone, without surgery,
for the relief of symptoms. Stages II,
III and IV (advanced) mesothelioma - Pleurectomy/decortication
may be performed to relieve symptoms in pleural mesothelioma. Other
procedures such as thoracentesis may be performed to drain pleural effusions
and prevent them from recurring. Radiation therapy and/or chemotherapy
may also be administered for symptom relief. Recurrent
malignant mesothelioma - There is no standard treatment for
recurrent mesothelioma; generally, treatments are chosen that were not
used in the first treatment attempt.
Mesothelioma
- Clinical Trials & Future Treatments New
treatments for malignant mesothelioma (and possible preventive measures,
such as a vaccine) are being evaluated in clinical trials, and the future
holds some promise. Clinical trials are research studies that evaluate
new treatments for safety and effectiveness. There are no guarantees
that a new treatment will work, and there are some risks; however, a
clinical trial is not undertaken unless the researchers believe the
treatment may have some value. Here
are some of the treatments for malignant mesothelioma that are being
evaluated:
- Combination
chemotherapy - Different combinations of chemotherapy drugs
have been tried with mixed results. A recent study showed some benefit
of combining cisplatin and gemcitabine. The researchers used the combination
to treat 21 patients with advanced mesothelioma, of whom 47 percent
showed a partial response.
Other
medications - One study showed that lovastatin, a cholesterol-lowering
drug, may be useful for the treatment of malignant mesothelioma. The
drug was found to induce apoptosis (cell death) in mesothelioma cells,
which may increase the effectiveness of radiation therapy and chemotherapy.
Intracavitary
chemotherapy - Instilling chemotherapy drugs directly into
the pleural or peritoneal space is being researched because of its
advantage over traditional chemotherapy: because the drug is instilled
directly into the cavity, much greater doses can be given to patients
without causing severe side effects. Some studies have shown this
therapy to result in control of effusions and reduced tumor size.
Brachytherapy
(intracavitary radiation therapy) - In this treatment, a
radioactive substance is placed directly into the pleural or peritoneal
space.
Multimodality
therapy - Any combination of surgery, radiation therapy and
chemotherapy is multimodality therapy. For example, researchers have
combined surgery with intracavitary radiation or chemotherapy and
then administered radiation or chemotherapy afterward. Some physicians
are administering chemotherapy before surgery in an attempt to decrease
the size of the tumor.
Gene therapy - In this approach, a virus that has been genetically altered is introduced
into the tumor. The virus infects the tumor cells and makes them vulnerable
to anticancer drugs.
Immunotherapy - Treatments that stimulate the body's immune system to fight
cancer cells are called immunotherapy.
- Photodynamic
therapy - In this treatment, drugs that are sensitive to
light are taken up by the tumor cells, which are then exposed
to light.
|